Skip to main content
SpringerLink
Log in

Disease Management Update

  • From The World Literature
  • Published:
Disease Management & Health Outcomes

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

Notes

  1. PharmacoEconomics & Outcomes News provides comprehensive coverage of the biomedical literature on health economics and outcomes research, and summarizes information selected from over 1600 journals.

  2. Costs were those related to prescription medications, outpatient and emergency-department visits, specialist consultations, laboratory tests, patient copayments, household items, childcare and lost productivity.

  3. Costs were those related to laboratory services, hospitalisation, long-term treatment and false-positive tests, and were discounted at 3% per annum.

  4. Costs were those associated with hospitalization, which included laboratory and radiography services, and pharmacy charges.

  5. Based on the Anatomical Therapeutic Chemical classification system (as used in the New Zealand pharmaceutical schedule).

  6. Costs were those related to clinical procedures, drug treatment, patient transportation and staff services.

  7. Modified version of the diabetes QOL instrument.

References

1. Insurance Coverage Has Little Effect on Smoking Cessation

  • Boyle RG, Solberg LI, Magnan S, et al. Does insurance coverage for drug therapy affect smoking cessation? A study in Minnesota found that drug coverage alone is not enough. Health Aff 2002 Nov–Dec; 21: 162–8

    Article  Google Scholar 

2. Healthcare Providers’ Attitudes to Clinical Practice Guidelines Positive

  • Farquhar CM, Kofa EW, Slutsky JR. Clinicians’ attitudes to clinical practice guidelines: a systematic review. Med J Aust 2002 Nov 2; 177: 502–6

    PubMed  Google Scholar 

3. Atopic Dermatitis Imposes Large Financial, Quality of Life Burden

  • Fivenson D, Goldberg Arnold RJ, et al. The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organization. J Manag Care Pharm 2002 Sep–Oct; 8: 333–42

    PubMed  Google Scholar 

4. Neonatal Screening for Metabolic Disorders Warranted in the US

  • Schoen EJ, Baker JC, Colby CJ, et al. Cost-benefit analysis of universal tandem mass spectrometry for newborn screening. Pediatrics 2002 Oct; 110: 781–6.

    Article  PubMed  Google Scholar 

5. India’s Tuberculosis Control Program ‘Remarkably Successful’

  1. Khatri GR, Frieden TR. Controlling tuberculosis in India. N Engl J Med 2002 Oct 31; 347: 1420–5.

    Article  PubMed  CAS  Google Scholar 

  2. Drazen JM. A milestone in tuberculosis control. N Engl J Med 2002 Oct 31; 347: 1444.

    Article  PubMed  Google Scholar 

6. Years of Healthy Life Can be Increased 5–10 Years, Says WHO Report

  • World Health Organization. Years of healthy life can be increased 5–10 years, WHO says [media release] 2002 Oct 30 Available from URL: http://www.who.int.

7. Quality of Antihypertensive Therapy Improved with Guideline Intervention

  • Avanzini F, Corsetti A, Maglione T, Studio per una Terapia Antipertensiva Razionale Investigators (Study on Rational Antihypertensive Therapy, STAR), et al. Simple, shared guidelines raise the quality of antihypertensive treatment in routine care. Am Heart J 2002 Oct; 144: 726–32.

    PubMed  Google Scholar 

8. Optimizing Clinical Guideline Use in Clinical Practice

  • Gallagher EJ. How well do clinical practice guidelines guide clinical practice?. Ann Emerg Med 2002 Oct; 40: 394–8.

    Article  PubMed  Google Scholar 

9. Preventive Practices for Diabetes Mellitus Increasing in the US

  • Lojo J, Burrows NR, Geiss LS, et al. Preventive-care practices among persons with diabetes - United States, 1995 and 2001. MMWR Morbidity and Mortality Weekly Report 2002 Nov 1; 51: 965–9.

    Google Scholar 

10. Psychotropic Medication Use Suboptimal in Europe

  • Ohayon MM, Lader MH. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry 2002 Sep; 63: 817–25.

    Article  PubMed  Google Scholar 

11. US Medicaid Interventions Improve Pediatric Asthma Care

  • Barta PJ, Carlson MJ, Ahl E. Improving care for children with asthma in two Medicaid health plans. J Clinl Outcomes Manag 2002 Oct; 9: 557–63.

    Google Scholar 

12. Disease Management (DM) Program Reduces Rehospitalizations in Congestive Heart Failure

  • Akosah KO, Schaper AM, Havlik P, et al. Improving care for patients with chronic heart failure in the community: the importance of a disease management program. Chest 2002 Sep; 122: 906–12.

    Article  PubMed  Google Scholar 

13. MedTake Test Assesses Drug Adherence in US Elderly

  • Raehl CL, Bond CA, Woods T, et al. Individualized drug use assessment in the elderly. Pharmacotherapy 2002 Oct; 22: 1239–48.

    Article  PubMed  Google Scholar 

14. Injudicious Use of Antibacterials Continues Among US Pediatricians

  • Nambiar S, Schwartz RH, Sheridan MJ. Are pediatricians adhering to principles of judicious antibiotic use for upper respiratory tract infections? South Med J 2002 Oct; 1 95: 1163–7.

    PubMed  Google Scholar 

15. Aminosalicylate Use Suboptimal in Ulcerative Colitis

  • Rubin G, Hungin APS, Chinn D, et al. Long-term aminosalicylate therapy is under-used in patients with ulcerative colitis: a cross-sectional survey. Aliment Pharmacol Ther 2002; 16: 1889–93.

    Article  PubMed  CAS  Google Scholar 

16. Using Pharmacoeconomics to Justify Use of Higher-Cost Drugs

  • Racine E. Justifying high-cost anticoagulant therapy. Am J Health-Syst Pharm 2002 Oct 15; 59 Suppl. 6: 18–20.

    Google Scholar 

17. UK NICE Guidance for Acetylcholinesterase Inhibitors Followed

  • Mace S, Taylor D. Adherence to NICE guidance for the use of anticholinesterases for Alzheimer’s disease. Pharmaceut J 2002 Nov 9; 269: 680–1.

    Google Scholar 

18. Asthma Hospitalization Prevented with Regular Corticosteroid Use

  • Suissa S, Ernst P, Kezouh A. Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma. Thorax 2002 Oct; 57: 880–4.

    Google Scholar 

19. Pediatric Hospitalist System Reduces Length of Stay and Costs

  • Landrigan CP, Srivastava R, Muret-Wagstaff S, et al. Impact of a health maintenance organization hospitalist system in academic pediatrics. Pediatrics 2002 Oct; 110: 720–8.

    Article  PubMed  Google Scholar 

20. Hypercholesterolemia Improved with Nurse Case-Management

  • Allen JK, Blumenthal RS, Margolis S, et al. Nurse case management of hypercholesterolemia in patients with coronary heart disease: results of a randomized clinical trial. Am Heart J 2002 Oct; 144: 678–86.

    PubMed  Google Scholar 

21. Prescribing in General Practice High Among New Zealand Elderly

  • Martin I, Hall J, Gardner T. Prescribing for patients aged 65 years and over in New Zealand general practice [online]. N Z Med J 2002 Oct 25; 115. Available from URL: http://www.nzma.org.nz/journal.

22. DM Program Improves Pediatric Asthma Management

  • Lukacs SL, France EK, Baron AE, et al. Effectiveness of an asthma management program for pediatric members of a large health maintenance organization. Arch Pediatr Adolesc Med 2002 Sep; 156: 872–6.

    PubMed  Google Scholar 

23. Cost of Osteoarthritis Varies with Definition Criteria

  1. Harrold LR, Yood RA, Straus W, et al. Challenges of estimating health service utilization for osteoarthritis patients on a population level. J Rheumatol 2002 Sep; 29: 1931–6.

    PubMed  Google Scholar 

  2. Maetzel A. The challenges of estimating the national costs of osteoarthritis: are we making progress? J Rheumatol 2002 Sep; 29: 1811–3.

    PubMed  Google Scholar 

24. Community-Based Directly Observed Therapy for Latent Tuberculosis Improves Completion Rates

  • Narita M, Kellman M, Franchini DL, et al. Short-course rifamycin and pyrazinamide treatment for latent tuberculosis infection in patients with HIV infection: the 2-year experience of a comprehensive community-based program in Broward County, Florida. Chest 2002 Oct; 122: 1292–8.

    Article  PubMed  CAS  Google Scholar 

25. Group Care Intervention ‘Feasible and Cost-Effective’ in Diabetes Mellitus

  • Trento M, Passera P, Bajardi M, et al. Lifestyle intervention by group care prevents deterioration of Type II diabetes: a 4-year randomized controlled clinical trial. Diabetologia 2002 Sep; 45: 1231–9.

    Article  PubMed  CAS  Google Scholar 

26. Shift in US Healthcare System ‘Embodies a Massive Force’

  • James B. Quality improvement opportunities in health care — making it easy to do it right. J Manag Care Pharm 2002 Oct; 8: 394–9.

    PubMed  Google Scholar 

27. Antiretrovirals: More Research Into Use in Resource-Poor Settings Needed

  • Rabkin M, El-Sadr W, Katzenstein DA, et al. Antiretroviral treatment in resource-poor settings: clinical research priorities. Lancet 2002 Nov 9; 360: 1503–5.

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Disease Management Update. Dis-Manage-Health-Outcomes 11, 129–137 (2003). https://doi.org/10.2165/00115677-200311020-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00115677-200311020-00007

Search

Navigation